NASDAQ:SEER Seer (SEER) Stock Price, News & Analysis → Investors Alert: The Next Big Thing in Weight Loss (From Behind the Markets) (Ad) Free SEER Stock Alerts $2.24 +0.08 (+3.70%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$2.18▼$2.2450-Day Range$1.66▼$2.2452-Week Range$1.46▼$5.65Volume232,183 shsAverage Volume565,173 shsMarket Capitalization$145.08 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Seer alerts: Email Address Seer MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside212.5% Upside$7.00 Price TargetShort InterestBearish5.96% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.04Based on 8 Articles This WeekInsider TradingSelling Shares$133,366 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.22) to ($1.18) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.93 out of 5 starsMedical Sector3571st out of 5,424 stocksAnalytical Instruments Industry121st out of 168 stocks 3.0 Analyst's Opinion Consensus RatingSeer has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageSeer has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.96% of the float of Seer has been sold short.Short Interest Ratio / Days to CoverSeer has a short interest ratio ("days to cover") of 5.7.Change versus previous month Previous Next 0.0 Dividend Strength Dividend YieldSeer does not currently pay a dividend.Dividend GrowthSeer does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SEER. Previous Next 1.7 News and Social Media Coverage News SentimentSeer has a news sentiment score of 0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Seer this week, compared to 5 articles on an average week. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Seer insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $133,366.00 in company stock.Percentage Held by Insiders15.02% of the stock of Seer is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions75.20% of the stock of Seer is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Seer are expected to grow in the coming year, from ($1.22) to ($1.18) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Seer is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Seer is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSeer has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsInvestors Alert: The Next Big Thing in Weight LossUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. Get the name of the stock here >>> About Seer Stock (NASDAQ:SEER)Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.Read More SEER Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SEER Stock News HeadlinesMay 2, 2024 | msn.comPralhad Joshi keen on fifth straight win in Dharwad LS seat, but seer’s shadow looms largeMay 1, 2024 | msn.comMinister eyes 5th win, but Lingayat seer stands in wayMay 4, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. May 1, 2024 | msn.comDingaleshwara seer to launch rallies after cancelling nominations for LS pollsApril 28, 2024 | msn.com‘Illinoise’ Review: A Thrilling, Genre-Defying Broadway Musical Brings the Sufjan Stevens Album to Lyrical LifeApril 28, 2024 | msn.comBritish Actress Amy Tara Joins Ben Pauling's Mystery-Thriller ‘Dream'April 28, 2024 | msn.com‘Illinoise’ review: Moving Broadway show is about love, loss — and danceApril 28, 2024 | msn.comAmid veteran vs fresher fight, all eyes on seer swing bowlingMay 4, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. April 23, 2024 | msn.comSC rejects Chitradurga Muruga mutt seer’s bail petition in 2022 Pocso caseApril 23, 2024 | globenewswire.comSeer to Report First Quarter 2024 Financial Results on May 8, 2024April 23, 2024 | msn.comDingaleshwar seer withdraws his candidacy against Pralhad JoshiApril 23, 2024 | msn.comBihar Lok Sabha Elections 2024: Key constituencies and candidates in Phase IIApril 22, 2024 | msn.comLingayat seer exits contest against Union minister Pralhad JoshiApril 22, 2024 | msn.comUP Lok Sabha Elections 2024: SP Chief Akhilesh Yadav Opts Out, RJD's Tej Pratap Yadav Steps In For Kannauj SeatApril 22, 2024 | msn.comLok Sabha elections 2024: Lingayat seer Dingaleshwar withdraws nomination from Hubballi-Dharwad seatApril 22, 2024 | msn.comLingayat seer Dingaleshwar Swami pulls out of Lok Sabha race from DharwadApril 22, 2024 | msn.comLingayat seer Dingaleshwar withdraws nomination from Hubballi-Dharwad seatApril 22, 2024 | msn.comSeer who wanted to take on BJP leader Pralhad Joshi in LS polls withdraws from raceApril 17, 2024 | msn.comLingayat seer meets Muslim religious leaders ahead of Lok Sabha election nominationApril 16, 2024 | msn.comSaffron army out in support of Dingaleshwar seerApril 15, 2024 | msn.comEerie Nostradamus predictions could have foreseen Iran-Israel conflictApril 15, 2024 | msn.comDid Nostradamus Predict Iran-Isarel Conflict? Seer's Eerie Prediction For 2024 Goes Viral Amidst WW3 ConcernsApril 13, 2024 | msn.comPick either polls or peetha: Devotees tell Dingaleshwar seerApril 12, 2024 | finance.yahoo.comSeer, Inc. (NASDAQ:SEER) is a favorite amongst institutional investors who own 51%April 11, 2024 | msn.comFemale Seer Who Foresaw Junior Pope's Death Speaks: "It Always Comes to Pass"April 11, 2024 | msn.comCongress, BJP-JDS alliance fight for Vokkaliga votes, seer blesses allSee More Headlines Receive SEER Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Seer and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/29/2024Today5/04/2024Next Earnings (Confirmed)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryN/A Current SymbolNASDAQ:SEER CUSIPN/A CIK1726445 Webwww.seer.bio Phone650-453-0000FaxN/AEmployees147Year FoundedN/APrice Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside+212.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.36) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-86,280,000.00 Net Margins-517.84% Pretax Margin-517.84% Return on Equity-20.87% Return on Assets-19.01% Debt Debt-to-Equity RatioN/A Current Ratio25.00 Quick Ratio24.66 Sales & Book Value Annual Sales$16.66 million Price / Sales8.71 Cash FlowN/A Price / Cash FlowN/A Book Value$6.17 per share Price / Book0.36Miscellaneous Outstanding Shares64,770,000Free Float55,044,000Market Cap$145.08 million OptionableOptionable Beta1.52 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesDr. Omid C. Farokhzad M.D. (Age 55)Ph.D., Founder, CEO, & Chair of the Board of Directors Comp: $1.23MMr. David R. Horn (Age 57)President,Treasurer & CFO Comp: $593.38kMs. Elona Kogan Esq. (Age 55)J.D., Chief Legal Officer,General Counsel & Secretary Comp: $548.42kMr. Joe LawsChief Technology Officer and Co-FounderKenny RossChief Operations & Product OfficerMs. Marissa DixonChief People OfficerDr. Serafim Batzoglou Ph.D.Chief Data OfficerMr. Martin Goldberg Ph.D.Senior Vice President of DevelopmentDr. Asim Siddiqui Ph.D.Senior Vice President of Research & Tech DevelopmentDr. Christopher E. Mason Ph.D.Member of Scientific Advisory BoardMore ExecutivesKey CompetitorsAkoya BiosciencesNASDAQ:AKYABionano GenomicsNASDAQ:BNGORapid Micro BiosystemsNASDAQ:RPIDNautilus BiotechnologyNASDAQ:NAUTPacific Biosciences of CaliforniaNASDAQ:PACBView All CompetitorsInsiders & InstitutionsMirae Asset Global Investments Co. Ltd.Bought 18,566 shares on 5/1/2024Ownership: 0.029%Omid FarokhzadSold 52,857 sharesTotal: $107,299.71 ($2.03/share)Syon Capital LLCBought 48,500 shares on 2/26/2024Ownership: 0.076%Elona KoganSold 12,684 sharesTotal: $20,040.72 ($1.58/share)Brandywine Managers LLCBought 44,552 shares on 2/15/2024Ownership: 0.070%View All Insider TransactionsView All Institutional Transactions SEER Stock Analysis - Frequently Asked Questions Should I buy or sell Seer stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Seer in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SEER shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SEER, but not buy additional shares or sell existing shares. View SEER analyst ratings or view top-rated stocks. What is Seer's stock price target for 2024? 1 analysts have issued 12-month price targets for Seer's stock. Their SEER share price targets range from $7.00 to $7.00. On average, they predict the company's stock price to reach $7.00 in the next year. This suggests a possible upside of 212.5% from the stock's current price. View analysts price targets for SEER or view top-rated stocks among Wall Street analysts. How have SEER shares performed in 2024? Seer's stock was trading at $1.94 on January 1st, 2024. Since then, SEER shares have increased by 15.5% and is now trading at $2.24. View the best growth stocks for 2024 here. When is Seer's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our SEER earnings forecast. How can I listen to Seer's earnings call? Seer will be holding an earnings conference call on Wednesday, May 8th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were Seer's earnings last quarter? Seer, Inc. (NASDAQ:SEER) released its quarterly earnings data on Thursday, February, 29th. The company reported ($0.28) EPS for the quarter, beating the consensus estimate of ($0.35) by $0.07. The company earned $4.44 million during the quarter, compared to analyst estimates of $4.24 million. Seer had a negative net margin of 517.84% and a negative trailing twelve-month return on equity of 20.87%. What guidance has Seer issued on next quarter's earnings? Seer issued an update on its FY 2024 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $18.0 million-$20.0 million, compared to the consensus revenue estimate of $19.8 million. When did Seer IPO? Seer (SEER) raised $150 million in an initial public offering (IPO) on Friday, December 4th 2020. The company issued 8,800,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, Morgan Stanley, BofA Securities and Cowen served as the underwriters for the IPO. Who are Seer's major shareholders? Seer's stock is owned by a number of institutional and retail investors. Top institutional investors include Mirae Asset Global Investments Co. Ltd. (0.03%). Insiders that own company stock include David R Horn, David R Horn, Elona Esq Kogan, Elona Kogan, Growth Fund Limited Part Amoon, Omead Ostadan, Omid Farokhzad and Scott D Thomas. View institutional ownership trends. How do I buy shares of Seer? Shares of SEER stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SEER) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seer, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
